Novartis, Pfizer, Sanofi: How India’s pharma GCCs transformed from back office to innovation powerhouse

They may have started out by processing routine tasks for global majors, but Indian pharma GCCs have now become a magnet for talent and investment as tech advances throw up new opportunities